Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Maximal dose")

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Origin

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 1062

  • Page / 43
Export

Selection :

  • and

L'approche américaine de la signification sanitaire des réactifs classiques dans le traitement des eaux = American approach of classical reagents sanitary meaning for water treatmentMASSCHELEIN, W. J.Technique de l'Eau et de l'Assainissement. 1983, Num 442-443, pp 16-18, issn 0040-120XArticle

Recent progress in the consideration of flavoring ingredients under the food additives amendment. XVI: GRAS substancesSMITH, R. L; FORD, R. A.Food technology (Chicago). 1993, Vol 47, Num 6, pp 104-117, issn 0015-6639, 7 p.Article

ANIMAL TOXICOLOGY FOR EARLY CLINICAL TRIALS WITH ANTICANCER AGENTSROZENCWEIG M; VON HOFF DD; STAQUET MJ et al.1981; CANCER CLIN. TRIALS; ISSN 0190-1206; USA; DA. 1981; VOL. 4; NO 1; PP. 21-28; BIBL. 15 REF.Article

VERFAHREN ZUR AUSWERTUNG VON RUECKSTANDSVERSUCHEN = METHODE D'INTERPRETATION DES RESULTATS D'ESSAIS SUR LES RESIDUS DE PESTICIDESWEINMANN WD; NOLTING HG.1981; NACHRICHTENBL. DTSCH. PFLANZENSCHUTZD. (BRAUNSCHWEIG); ISSN 0027-7479; DEU; DA. 1981; VOL. 33; NO 9; PP. 137-141; ABS. ENG; BIBL. 14 REF.Article

Ototoxizitäts-Grenzdosen = Ototoxicité ― doses limites = Ototoxicity ― maximal posologyFEDERSPIL, P.HNO. Hals-, Nasen-, Ohrenärzte. 1984, Vol 32, Num 10, pp 417-418, issn 0017-6192Article

Vebraucherschutz ist garantiert. Färbemittel in kosmetischen Produkten sind unbedenklich = La protection des consommateurs est assurée. Les colorants des cosmétiques sont non toxiques = Consumer protection is guaranteed. The cosmetic dyes are non-toxicSÖFW. Seifen, Öle, Fette, Wachse. 1983, Vol 109, Num 20, pp 597-599, issn 0173-5500Article

The maximum tolerated dose : the debateMCCONNELL, E. E.Journal of the American College of Toxicology. 1989, Vol 8, Num 6, pp 1115-1120, issn 0730-0913, 6 p.Conference Paper

Reconsideration of area correction factor for CRE and TDF models = Reconsidération du facteur de correction de surface des modèles CRE et TDFGUPTA, M. K.British journal of radiology. 1984, Vol 57, Num 674, pp 188-190, issn 0007-1285Article

Phase I clinical studies with cytotoxic drugs: pharmacokinetic and pharmacodynamic considerationsNEWELL, D. R.British journal of cancer. 1990, Vol 61, Num 2, pp 189-191, issn 0007-0920Article

Dosisberechnung sehr kleiner irregulärer Elektronen-bestrahlungsfelder. I, Dosisberechnung auf dem Zentralstrahl mit einer einfachen Feldzonenmethode = Dose calculation for very small irregular electron beams. 1. Part : Dose calculation on the central beam axis by a simple beam-zone methodGUTT, V. F; KUPHAL, K; HODAPP, N et al.Strahlentherapie und Onkologie. 1990, Vol 166, Num 9, pp 603-609, issn 0179-7158Article

Precise upper bounds for the functionals describing tumour treatment efficiencyHANIN, L. G; RACHEV, S. T; GOOT, R. E et al.Lecture notes in mathematics. 1989, Vol 1412, pp 50-67, issn 0075-8434, 18 p.Conference Paper

Gefährdung von Mensch und Umwelt durch Pflanzenschutzmittel = Dangers des produits phytosanitaires pour l'homme et la nature = Danger of agrochemicals for man and natureMACHEMER, L. H.1986, Vol 39, pp 1-19Article

Intranasally applied recombinant leukocyte A interferon in normal volunteers. II: Determination of minimal effective and tolerable doseSAMO, T. C; GREENBERG, S. B; PALMER, J. M et al.The Journal of infectious diseases. 1984, Vol 150, Num 2, pp 181-188, issn 0022-1899Article

Multifractionated dosing for cancer chemotherapy : A novel schedule and a work in progressLOKICH, J.Cancer investigation. 1999, Vol 17, Num 7, pp 551-554, issn 0735-7907Article

Nicotinamide pharmacokinetics in normal volunteers and patients undergoing palliative radiotherapySTRATFORD, M. R. L; DENNIS, M. P; HOSKIN, P. J et al.Acta oncologica (Stockholm). 1996, Vol 35, Num 2, pp 213-219, issn 0284-186XArticle

STRAIN DIFFERENCES IN MINIMUM ANESTHETIC CONCENTRATIONS IN DROSOPHILA MELANOGASTERGAMO S; OGAKI M; NAKASHIMA TANAKA E et al.1981; ANESTHESIOLOGY; ISSN 0003-3022; USA; DA. 1981; VOL. 54; NO 4; PP. 289-293; BIBL. 22 REF.Article

LITHIUM CARBONATE AND GRANULOCYTE PRODUCTION: DOSE OPTIMIZATIONSTEIN RS; HOWARD CA; BRENNAN M et al.1981; CANCER; ISSN 0008-543X; USA; DA. 1981; VOL. 48; NO 12; PP. 2696-2701; BIBL. 29 REF.Article

CLINICAL TRIAL OF DROPERIDOL FOR THE DETERMINATION OF THE NEUROLEPTIC THRESHOLD AND THE NEUROLEPTIC-THERAPEUTIC RANGEHAASE HJ; KAUMEIER S; SCHWARZ S et al.1980; INTERNATION. PHARMACOPSYCHIATRY; CHE; DA. 1980; VOL. 15; NO 1; PP. 74-80; BIBL. 7 REF.Article

HIGH DOSE METHOTREXATE WITH LEUCOVORIN RESCUE: RATIONALE AND SPECTRUM OF ANTITUMOR ACTIVITYFREI E III; BLUM RH; PITMAN SW et al.1980; AMER. J. MED.; USA; DA. 1980; VOL. 68; NO 3; PP. 370-376; BIBL. 34 REF.Article

PROBLEMES DE RADIOPROTECTION POSES PAR LES IRRADIATIONS EXTERNES DANS LES UNITES ANIMALESDUTREIX A.1979; SCI. TECH. ANIMAL LAB.; FRA; DA. 1979; VOL. 4; NO 2; PP. 89-93; ABS. ENG; BIBL. 4 REF.Article

SUSTAINED BROMOCRIPTINE THERAPY IN PREVIOUSLY UNTREATED PATIENTS WITH PARKINSON'S DISEASELEES AJ; STERN GM.1981; J. NEUROL. NEUROSURG. PSYCHIATRY; ISSN 0022-3050; GBR; DA. 1981; VOL. 44; NO 11; PP. 1020-1023; BIBL. 9 REF.Article

PILOT STUDIES OF VARIOUS COMBINATIONS OF DIBROMODULCITOL, VP-16, AND AMSAEAGAN RT.1982; ONCOLOGY; ISSN 0030-2414; CHE; DA. 1982; VOL. 39; NO 5; PP. 295-297; BIBL. 5 REF.Article

Effects of Maximal Doses of Atorvastatin Versus Rosuvastatin on Small Dense Low-Density Lipoprotein Cholesterol LevelsAI, Masumi; OTOKOZAWA, Seiko; ASZTALOS, Bela F et al.The American journal of cardiology. 2008, Vol 101, Num 3, pp 315-318, issn 0002-9149, 4 p.Article

Liposuktion in Tumeszenzlokalanästhesie: Grenzen der Prilocaindosierung = Liposuction in tumescent local anaesthesia : Maximum recommended doses for prilocaineMANG, W. L; MATERAK, J; KUNTZ, S et al.H + G. Zeitschrift für Hautkrankheiten. 1999, Vol 74, Num 3, pp 157-161, issn 0301-0481Article

Choice of starting dose and escalation for phase I studies of antitumor agentsPENTA, J. S; ROSNER, G. L; TRUMP, D. L et al.Cancer chemotherapy and pharmacology. 1992, Vol 31, Num 3, pp 247-250, issn 0344-5704Article

  • Page / 43